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Abstract.  We have constructed and expressed a  series 
of mutant influenza virus hemagglutinins, each con- 
taining a  new consensus site for glycosylation in addi- 
tion to the seven sites found on the wild-type protein. 
Oligosaccharide side chains were added with high 
efficiency at four of the five novel sites, located on 
areas of the protein's surface that are not normally 
shielded by carbohydrate. Investigations of the struc- 
ture,  intracellular transport, and biological activities of 
the mutant hemagglutinin molecules indicated that (a) 
supernumerary carbohydrate side chains can be used 
to shield or disrupt functional epitopes on the surface 
of hemagglutinin, and (b) the presence of an additional 
oligosaccharide may cause temperature-dependent 
defects in the transport of the glycoprotein. We discuss 
the addition of supernumerary oligosaccharides as a 
general tool for shielding chosen areas of the surface 
of proteins that enter or traverse the secretory pathway. 
T  riE functions of the carbohydrate side chains that are 
covalently attached to the majority of eukaryotic mem- 
brane and secretory proteins are not yet fully under- 
stood. It has been suggested that N-linked oligosaccharides 
may play a variety of roles including (a) the maintenance of 
the structure and stability of glycoproteins, (b) the direction 
of proteins to various subcellular compartments both after 
biosynthesis and for degradation, and (c) recognition func- 
tions in specific adhesion of cells and tissue organization 
during development or neoplasia (for reviews see Gibson et 
al., 1980;  Elbein,  1981, 1987; Olden et al.,  1985).  Studies 
using drugs that are  specific inhibitors of the addition or 
modification of N-linked oligosaccharide side chains have 
been performed in attempts to define the functional roles of 
these carbohydrate moieties (for review see Elbein,  1987). 
The advent of recombinant DNA technology has facilitated 
studies  involving the  removal of individual glycosylation 
sites  via  oligonucleotide mutagenesis  (Machamer  et  al., 
1985;  Miyazaki et al.,  1986;  Santos-Aguado et al.,  1987; 
Guan et al., 1988; Matzuk and Boime, 1988). The majority 
of these investigations have indicated that oligosaccharide 
side chains indeed play a role in glycoprotein structure and 
stability, with different proteins being more or less depen- 
dent on the presence of their carbohydrate moieties (Elbein, 
1987).  Oligonucleotide-directed mutagenesis has also been 
used to cause the addition of oligosaccharide chains at novel 
positions on nascent polypeptides, which in some but not all 
cases promoted the intracellular transport of mutant proteins 
that were previously blocked in transport along the secretory 
pathway (Guan et al., 1985; Machamer et al., 1985; Mach- 
amer and Rose,  1988a, b).  Because the three-dimensional 
structures of  these proteins were not known, it was not possi- 
ble to predict whether the novel side chains would be at- 
tached at positions normally located on the surface or within 
the interior of the wild-type protein. In this paper we have 
taken  advantage  of the  knowledge  of the  precise  three- 
dimensional structure of the hemagglutinin (HA) t of influ- 
enza virus to introduce novel oligosaccharide consensus se- 
quences at chosen sites on the surface of the protein. 
HAs comprise a large family of highly polymorphic glyco- 
proteins which may vary up to 60% in amino acid sequence 
while still retaining very similar structural and biological 
properties (Wilson et al., 1981; Wiley et al., 1981). This ex- 
tensive  sequence  variation,  which  allows  newly  evolved 
viruses  to  escape  immunity acquired by the  host during 
previous infection, may either occur gradually by the ac- 
cumulation of single amino acid changes (antigenic drift), or 
abruptly after the introduction of a novel HA gene from an 
animal reservoir (antigenic shift) (reviewed by Air et al., 
1987).  There is also considerable variation in the position 
and number (four to nine) of potential carbohydrate attach- 
ment sites on the different HA molecules (Klenk, 1980; Wil- 
son et al.,  1983;  Keil et al.,  1984;  Wilson, I. A., unpub- 
lished observations). Occasionally, when antigenic shift or 
drift creates a novel consensus sequence (Asn-X-Ser or Thr) 
for N-linked glycosylation, the addition of the new oligosac- 
1. Abbreviations  used in this paper:  endo H, endoglycosidase H; ER, en- 
doplasmic reticulum; HA, hemagglutinin; HA0, eore-glycosylated precur- 
sor form; XHA, wild-type X31  hemagglutinin. 
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cule by shielding an antigenic epitope (Wiley et al., 1981; Ca- 
ton et al.,  1982; Raymond et al.,  1986). This strategy for 
evasion of immune recognition has been reproduced in the 
laboratory; a virus selected by growth in the presence of an 
anti-HA mAb was found to bear an altered HA containing 
an  additional  oligosaccharide  side  chain  (Skehel  et  al., 
1984). This side chain was attached near to, but not within, 
the target antigenic epitope. Because evasion of the immune 
system appears  to be the  major evolutionary pressure on 
influenza virus, it might be expected that, with time, oligo- 
saccharide side chains would progressively cover more of the 
surface of  the HA molecule. Comparison of  the carbohydrate 
attachment sites on a large number of HA variants reveals 
that, although the majority of the protein's surface has been 
shielded by an oligosaccharide at one time or another during 
the evolution of the molecule, five surface areas appear al- 
ways to have lacked carbohydrate. 
Why  has  there  been  selection against  the  presence  of 
oligosaccharide side chains within these five carbohydrate- 
free surface regions? In only one case is there an obvious rea- 
son for the absence of the N-linked side chain. At the apex 
of the molecule, near the contact points between the globular 
domains of the three subunits, there is a sialic acid-binding 
site involved in the attachment of virus to host cells (Wilson 
et al.,  1981). Carbohydrate residues  shielding  this  region 
would  mask  the  binding  site  and  abolish  infectivity. We 
postulate that other regions of HA that must remain devoid 
of carbohydrate might include recognition site(s) for putative 
cellular proteins involved in the initial folding and mobiliza- 
tion of HA into the secretory pathway (e.g., BiP; Gething et 
al., 1986b), and/or in the directional transport of HA to the 
apical  surface  of  polarized  epithelial  cells  (Rodriguez- 
Boulan and Sabatini, 1978; Blobel, 1980; Fitting and Kaba.t, 
1982). Alternatively, exclusion of carbohydrate from surface 
areas might occur for structural reasons.  Attachment of a 
carbohydrate side chain at some positions could interfere ei- 
ther with correct folding and oligomerization of the molecule 
(Gething et al.  1986b), or with assembly of HA into infec- 
tious virions. 
To analyze these and other possibilities we have used site- 
directed mutagenesis to introduce nucleotide sequences en- 
coding novel glycoslyation sites into the cloned copy of the 
gene encoding the X31 HA. This paper described the charac- 
terization of five mutant glycoproteins each of which has a 
novel consensus sequence located within one of the carbo- 
hydrate-free regions on the surface of the molecule. We have 
shown that the addition  of a  supernumerary carbohydrate 
side chain can be used to shield or disrupt functional epitopes 
on the surface of the HA molecule. We have also found that 
the presence of a novel side chain can cause temperature- 
dependent defects in the intracellular transport of the glyco- 
protein. However, these transport defects result from gener- 
alized effects on the folding of the HA molecule, rather than 
from shielding of a specific transport epitope on the surface 
of the protein. 
Materials and Methods 
Selection of  Novel Consensus Sequence Sites 
The three-dimensional structure of the A/Aichi/68 (X31) HA (Wilson et al., 
1981) was displayed on an Evans and Sutherland color multi-picture system. 
Analysis of the protein structure was performed using a Digital Electronic 
Corp.  (Marlboro, MA) VAX 11/750. The structure representations were 
projected using ORAMPS  (O'Donneli and Olson,  1981) and GRANNY 
(Connolly and Olson,  1985)  programs. The HAl  amino acid sequences 
reported for 47 HA variants and the HA2 sequences reported for 22 of  these 
variants were collated and the positions of all the potential glycosylation 
sites on the HA proteins were noted. The positions of all the residues that 
have, in one sequence or another, been the asparagine of a canonical gly- 
cosylation sequence were amassed on the X31 structure and the projected 
surface areas that would be masked by the attached side chains were high- 
lighted. Areas of  the surface of  the HA trimer which appeared never to have 
been shielded by carbohydrate were noted and approximate locations were 
selected for the attachment of novel oligosaccharides that would cover these 
areas. Precise selection of residues to be altered to yield new canonical se- 
quences using the criteria described in the results section was made using 
a three-dimensional molecular model based on the coordinates determined 
by  x-ray crystallography (Wilson et al.,  1981) and constructed by John 
Mack. 
Recombinant DNA Techniques 
Buffers and reaction conditions for restriction enzymes, T4 DNA ligase, and 
the Klenow fragment of DNA polymerase I were those listed by the com- 
mercial source New England Biolabs (Beverly,  MA).  Isolation of DNA 
fragments, preparation of plasmid DNAs, and other standard recombinant 
DNA techniques were carried out as described (Sambrook et al., 1988, and 
in other references cited therein). Transformation of Escherichia  coli DH1 
or TG1  cells was done by the method of Hanahan (1983). 
Site-specific Mutagenesis of  HA cDNA Using 
Mismatched Oligonucleotides 
Plasmid pSVEXHA (which contains a full length cDNA copy of the HA 
gene from influenza virus  strain A/Aichi/68  [Doyle et  al.,  1986])  was 
digested with Pst I and Bam HI restriction endonucleases, and a 2,579-bp 
DNA fragment (including 771 bp of pBR322 sequences that lie between the 
Pst I and Cla I restriction sites and 1,608 bp encoding the ectodomain of 
X31 HA) was purified by gel electrophoresis. This fragment was inserted 
between the Pst I and Bam HI site of the double-stranded replicative form 
of Ml3mpl9 phage DNA, and E. coli TG1 cells were transfected with the 
ligated DNA molecules. A recombinant phage was selected in which the 
single-stranded DNA purified from M13 virions secreted from infected bac- 
terial cells contained the coding sequences of HA cDNA. Six 20-mer oligo- 
nucleotides were synthesized to be complementary, except for the required 
mismatches, to HA cDNA sequences encoding regions of the protein where 
amino acid substitutions were planned to introduce novel Ash, Ser, or Thr 
residues. The procedures used to carry out oligonucleotide-directed muta- 
genesis and identification of the desired mutants have been described in de- 
tail in Zoller and Smith (1983,  1985) and in Doyle et al. (1986).  Once the 
desired base substitutions had been confirmed, the double-stranded replica- 
five form of the phage DNAs containing each mutant HA sequence was pre- 
pared and purified by centrifugation on CsC12 gradients. The 1,608-bp Cla 
I-Bam HI DNA fragment encoding the X31 HA ectodomain was isolated 
and used to replace the equivalent wild-type sequences in the SVEXHA 
recombinant viral genome. 
Generation of  SV40-HA Recombinant Virus Stocks 
and Infection of  CV-1 Cells 
SV40-HA recombinant genomes containing wild-type and mutant forms of 
the X31 HA gene were transfected into CV-1 ceils using DEAE-dextran and 
chloroquine as previously described (Doyle et al., 1985).  High-titer virus 
stocks were developed and used to infect fresh monolayers of CV-1 cells for 
analysis of the biosynthesis and intracellular transport of the wild-type and 
mutant HAs. Conditions for growth and infections of CV-I cells were as de- 
scribed previously (Doyle et al.,  1985). 
Analysis of  the Biosynthesis and Intracellular 
Processing of Wild-type and Mutant HAs 
Analysis of the biosynthesis of wild-type and mutant HA proteins at 37°C 
was carried out by pulse-chase radiolabeling of infected cells with [35S]me- 
thionine as described by Gething et al.  (1986b).  When it was desired to 
block N-linked glycosylation of the HA molecules, tunicamycin (5 gg/ml) 
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procedure. Cell extracts were immunoprecipitated with a polyclonal anti- 
X31  HA rabbit antiserum as described by Gething et al. (1986b), or with 
mAbs as previously described by Webster et al. (1983). The mAbs used in 
this study (11/4 [A site], 17/2 [B site], 69/1  [C site], and 78/6 [D site]) were 
generously provided by R. Webster, St. Jude Children's Research Hospital, 
Memphis, TN. Digestion with endo-N-acetylglucosaminidase H (end<) H) 
was carried out as described (Owen et al.,  1980). Binding of guinea pig, 
human, turkey, or chicken erythrocytes to HA expressed on the surface of 
infected CV-1 cells was performed as described previously (Doyle et al., 
1985). The cellular location of wild-type and mutant forms of HA was de- 
termined by indirect immunofluorescence of infected cells (Doyle et al., 
1985; Ash et al., 1977) using the polyclonal and monoclonal antibodies de- 
scribed above. 
Analysis of the biosynthesis of the wild-type and mutant proteins at 30 
and  42°C  was  carried  out  as  described  for  37°C,  with  the  following 
modifications. CV-1 cells were infected with recombinant viruses and in- 
cubated at 37°C for 36~10 h. Before labeling, the infected cells were prein- 
cubated at either 30°C for 2 h or at 42°C for 30 min. During the labeling 
and chase periods, these temperatures were accurately maintained until cell 
extracts were prepared.  Cell fusion, erythrocyte binding, and indirect im- 
munofluorescence assays which require an accumulation of sufficient HA 
on the plasma membrane for determination of biological activity were car- 
ried out with the following modifications. CV-1 cells infected with recom- 
binant viruses were incubated at 37°C for 18 h. At this time, just before the 
commencement of synthesis of HA, the infected cells were incubated at 
30°C for an additional 48 h to ensure that all HA appearing and accumulat- 
ing on the plasma membrane had been synthesized at 30°C. 
Enumeration of the Oligosaccharide Side Chains 
on HA Molecules Using Partial Digestion with 
Endo-N-acetylglucosaminidase  H 
Infected cells were pulse labeled with [35S]methionine for 5 rain at 37°C. 
The monolayers were then washed once with Tris-buffered saline and cell 
extracts were prepared as described previously (Gething and Sambrook, 
1981).  Proteins immunoprecipitated using anti-HA serum were digested 
with endo H (ICN Immunobiologicals, Inc., Irvine, CA; 1.0 mlU per sam- 
ple) as described by Owen et al., 1980 for various times between 0 rain and 
3 h. At each time point an aliquot was removed and added to an equal vol- 
ume of gel sample buffer (Gething et al.,  1986b).  The samples were then 
analyzed by SDS-PAGE and autoradiography. 
Protease Sensitivity of Wild-type and Mutant 
HA Molecules 
Cell extracts were prepared from infected cells using a lysis buffer lacking 
protease inhibitors (50 mM Tris-HC1, pH 8.0, containing 1% NP-40). Ali- 
quots of the extracts were incubated on ice for 15 min either in the absence 
or presence of 25 ~tg/ml trypsin before the addition of a twofold excess of 
soybean trypsin inhibitor. After immunoprecipitation using anti-HA sera, 
the digestion products were analyzed by SDS-PAGE and autoradiography. 
Results 
Identification of Surface Regions on HA That 
Normally Lack Carbohydrate and Choice of Novel 
Sites for Glycosylation 
Areas on the surface of  the HA molecule that have never been 
covered by an oligosaccharide in any known influenza virus 
variant were identified by locating on a molecular graphics 
display of the X31 HA structure the positions of all potential 
glycosylation sites within the sequences of HAs of 47 differ- 
ent influenza A  virus strains (see Materials and Methods). 
These sites can be grouped into three classes: those whose 
position  is  conserved in  all  HA  molecules,  those whose 
general location on the protein surface remains  relatively 
constant although the specific point of linkage to the poly- 
peptide chain may vary, and those that are attached at quite 
different positions on different molecules. The solvent-ac- 
cessible surface area that would be "masked" by the oligosac- 
charides  was  estimated and  highlighted  on the  molecular 
graphics display.  Several surface areas which  were never 
glycosylated were distinguished. 
We wished to introduce novel consensus sequences (Asn- 
X-Ser/Thr) so as to maximize the shielding of the carbohy- 
drate-free regions while minimizing disruption of the struc- 
ture of the HA trimer. The choice was first limited to amino 
acids that lay in the center of each barren region and were 
clearly exposed on the  surface of the  protein.  Secondly, 
amino acids that were highly conserved between different 
HAs or that appeared to play an important role in maintain- 
ing the  structure of the protein were excluded.  The final 
criterion was that the residue designated for attachment of 
the extra oligosaccharide should have its side chain directed 
outward from the surface of the protein so as to minimize 
structural distortion caused by the addition of the oligosac- 
charide  to  the  E-amino  group  of  the  novel  or  natural 
asparagine residue. The positions on the X31 HA molecule 
that were chosen for attachment of supernumerary carbohy- 
drate side chains and the amino acid changes that were intro- 
duced  by  site-directed  mutagenesis  to  create  the  novel 
glycosylation sites are shown in Table I and in the summary 
Fig. 7. Within two of the barren areas, at residues 54 and 188, 
a  suitable asparagine  was  available whose side chain was 
directed outward; the consensus site could be introduced by 
substituting a threonine or serine residue for the amino acid 
located two residues further along the polypeptide chain. Be- 
cause the presence of proline at the central position of the 
consensus  site has been reported to prevent glycosylation 
(Neuberger et al., 1972), a secondary mutant (54B) was con- 
structed in which proline 55 was substituted by glycine, the 
amino acid which is present in this position in the majority 
of HA molecules whose sequence is known.  In two other 
barren areas,  threonine or serine residues  lay two amino 
acids downstream of residues (46 and 225) that were suitable 
for substitution by asparagine.  In the final barren region, 
both the asparagine (at position 476 [HA2 position 147]) and 
the threonine residue had to be introduced by mutagenesis. 
Table L Nucleotide Substitutions and Corresponding 
Amino Acid Changes in Mutants with Supernumerary 
Consensus Sequences  for Glycosylation 
Name  Sequence of wild-type  Sequence of mutant 
XHA46 +  Ser-Ser-Thr  Asn-Ser-Thr 
TCC-TCA-ACG  AAC-TCA-ACG 
XHA54A +  Asn-Pro-His  Asn-Pro-Thr 
AAT-CCT-CAT  AAT-CCT-ACT 
XHA54B +  Asn-Pro-Thr*  Asn-Gly-Thr 
AAT-CCT-ACT  AAT-GGT-ACT 
XHA 188 +  Asn-Gln-Glu  Asn-Gln-Ser 
AAC-CAA-GAA  AAC-CAA-ACA 
XHA225 +  Gly-Leu-Ser  Asn-Leu-Ser 
GGT-CTG-TCT  AAT-CTG-TCT 
XHA476 +  Ala-Cys-Ile  Asn-Cys-Thr 
GCT-TGC-ATA  AAT-TGC-ACA 
* DNA from the XHA54A+ mutant was used as the template for mutagenesis 
to generate the XHA54B +  mutant. 
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Containing Novel Glycosylation Sites 
Oligonucleotide-directed mutagenesis of cloned X31 eDNA 
was used to introduce the nucleotide changes (Table I) re- 
quired to encode the novel consensus sites for glycosylation. 
To  analyze the  phenotypes  of the  mutant glycoproteins, 
SV40-HA recombinant genomes were constructed in which 
either the wild-type X31 HA gene (XHA) or the mutant genes 
(46+, 54A+, 54B+, 188+, 225+, and 476+) replaced the 
coding sequences of the late region of SV-40 DNA. These 
recombinant genomes  were  transfected into  simian  CV-1 
cells and high titer recombinant virus stocks were developed. 
After infection of fresh monolayers of CV-1 cells with these 
stocks, a number of different assays were performed to ana- 
lyze the phenotypes of the wild-type and mutant XHA pro- 
teins.  The  details  of all  these  procedures  are  given  in 
Materials and Methods. 
Analysis of  the Number of  N-linked Side Chains 
on Vc~ld-type  and Mutant XHA Molecules 
To determine whether the novel consensus sequences were 
recognized as additional sites for N-linked glycosylation of 
the nascent polypeptide chain, the electrophoretic mobility 
of the core-glycosylated  precursor form (HAD) of each of the 
mutant proteins was compared with that of wild-type XHA. 
Fig. 1 A shows the results obtained when cells expressing the 
wild-type and mutant proteins were labeled with [3~S]me- 
thionine at 370C. The major protein band precipitated from 
the labeled cell extracts with anti-HA serum corresponds to 
HAl) (80 kD). A fainter band ('~55 kD) corresponds to the 
core-glycosylated  HA1 subunit, generated by partial proteol- 
ysis of newly synthesized monomeric HA0 after preparation 
of cell extracts (our unpublished data). The autoradiograph 
also reveals  a protein species (,,077 kD) that coprecipitates 
with the HA polypeptides. We have previously identified this 
protein, which is seen to associate to greater or lesser extents 
with the wild-type and mutant forms of HA in all the au- 
toradiographs presented in this paper, as the immunoglobu- 
lin heavy chain binding protein BiP, a cellular protein resi- 
dent in the lumen of the endoplasmic reticulum (ER) (Bole 
et al., 1986). BiP interacts with HA molecules until they be- 
come assembled into their native trimeric structure and are 
transported via the Golgi apparatus to the cell surface (Geth- 
ing et al.,  1986b). 
The HA0 forms of mutants 46+, 54B+, 188+, and 476+ 
labeled during a  5-min pulse migrated more  slowly than 
wild-type HAD (Fig. 1 A). However, the wild-type and mu- 
tant proteins synthesized in the presence of  tunicamycin (Fig. 
1 B) migrated with identical apparent molecular masses, in- 
dicating that the differences in mobility of the HA0 species 
seen in Fig. 1 A reflect changes in the complement of carbo- 
hydrate side chains rather than alterations to the polypeptide 
backbone.  The  presence  of additional  carbohydrate  side 
chains on these mutants is more apparent after cleavage of 
the precursor into HA1 and HA2 subunits (see below; Fig. 
3). As expected, increased mobility is displayed by the HA1 
subunits of mutants 46+, 54B+, and 188+, and by the HA2 
subunit of mutant 476+. 
The glycosylated forms of mutants 54A+ and 225+  mi- 
grated with the same mobility as the wild-type HA (Fig.  1 
A) suggesting that the new consensus sequences were not 
used for glycosylation. It is likely that a turn in the polypep- 
tide chain caused by the proline residue in the Asn~-Pro- 
Thr  sequence  prevents  simultaneous  recognition  of  the 
asparagine and threonine residues by the glycosyl transferase 
(Bause,  1983),  since  substitution  of glycine  for  proline 
resulted in supernumerary glycosylation of the 54B+  mu- 
tant. The structural basis for the lack of use of the novel site 
in the 225+  mutant is less easily understood. Inspection 
using molecular graphics of the positions of amino acids in 
the vicinity of residue 225 in the final conformation of the 
wild-type protein reveals  that the aromatic ring of Trp 222 
lies 4.9 A above the Ca atom of Gly 225.  Since we do not 
know the conformation of the mutant protein at the time of 
glycosylation, it is difficult to judge whether this bulky resi- 
due could sterically hinder the access of the glycosyl trans- 
ferase to the introduced asparagine residue in mutant 225+. 
Accurate  analysis of the  number  of carbohydrate  side 
chains on each mutant was carried out as described by Schuy 
et al. (1986) by partial digestion with endo H of HA mole- 
cules pulse-labeled for 5 min at 37°C, followed by separation 
of the reaction products by SDS-PAGE.  Examples of these 
analyses for the wild-type and two of the mutant HAs (46+ 
and 476+) are presented in Fig. 2. At each time point a series 
of discrete bands are seen, each differing by one N-linked 
oligosaccharide, and the total number of side chains on the 
wild-type or mutant HA molecules can be determined by 
counting the total number of bands. We confirmed the previ- 
ous reports of seven N-linked side chains on the XHA (Naka- 
mura and Compans,  1979;  Wilson et al.,  1981). Mutants 
46+,  54B+,  188+,  and 476+  each contained eight side 
chains, verifying that the novel consensus sequence in each 
of these proteins was used efficiently.  Mutants 54A+  and 
225+  contained only seven N-linked side chains. 
Analysis of  the IntraceUular Transport and 
Processing of  the V~ld-type  and Mutant XHA Proteins 
In a standard pulse-chase protocol, acquisition by a glyco- 
protein of resistance to cleavage of its N-linked oligosaccha- 
rides by endo H  provides a convenient measure of transit 
time from the ER into the medial Golgi cisternae (Kornfeld 
and Kornfeld, 1985).  The mutant proteins displayed exten- 
sive variation in their rate of acquisition of resistance to the 
glycosidase after synthesis at 37°C. Densitometric analysis 
of  the autoradiographs from these experiments allowed quan- 
titation of the percentage of HA molecules that had become 
resistant to endo H at the different times after synthesis (Ta- 
ble II). Two mutants (46+ and 225 +) were processed at rates 
very similar to that of the wild-type protein. Mutants 54A+, 
54B+, and 188+  were processed more slowly and mutant 
476+  showed very little conversion ("o7%  during a  2-h 
chase period) to a form resistant to the glycosidase, suggest- 
ing that this mutant protein is largely restricted to the ER. 
The time course of appearance of newly synthesized pro- 
tein on the plasma membrane was assayed by analyzing its 
accessibility to proteolysis by trypsin added to the external 
medium (Doyle et al.,  1986).  Previous experiments have 
shown that >90% of the radiolabeled, wild-type XHA pro- 
tein becomes accessible to exogenously  added trypsin within 
2 h of chase (Doyle et al., 1986). The results of the analysis 
of the wild-type and mutant glycoproteins after a 2-h period 
of chase at 37°C are shown in Fig. 3 A. Densitometric analy- 
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type  XHA  and  mutant  proteins 
containing supernumerary sites for 
N-linked glycosylation.  CV-1 cells 
infected  for  40  h  at  37°C  with 
SV40-HA recombinant viruses were 
labeled for 5 min with [35S]methi- 
onine in the absence (A) or pres- 
ence (B) of tunicamycin as described 
in Materials and Methods. Cell ex- 
tracts were then prepared  and HA 
polypeptides were precipitated with 
a polyclonal anti-HA serum, sepa- 
rated  by SDS-PAGE,  and autora- 
diographed. 
Gallagher et al. Effect of Supernumerary Oligosaccharides on Influenza HA  2063 Figure 2. Analysis of  the num- 
ber of  carbohydrate side chains 
on wild-type and mutant XHA 
proteins  by  partial  digestion 
with  endo  H.  CV-I cells  in- 
fected  for 40 h  at  37°C  with 
SV40-HA  recombinant  vi- 
ruses were labeled  for 5  min 
with [35S]methionine. Cell ex- 
tracts were then prepared and 
HA polypeptides  were precip- 
itated with  a polyclonal  anti- 
HA serum.  The immunopre- 
cipitates  were then treated  for 
0.5 min to 3 h with endo H as 
described  in  Materials  and 
Methods.  The reaction prod- 
ucts  were separated  by SDS- 
PAGE and autoradiographed. 
The  duration  of  treatment 
with endo H is shown in min- 
utes  except  for the  3-h time 
point. 
sis  of the  HA0,  HA1,  and  HA2  bands  revealed  extensive 
differences in the rate at which the mutants reached the cell 
surface at 37°C.  Mutant 46+  became accessible to trypsin 
at a rate similar to that of  the wild-type protein, while a larger 
proportion of the other mutants remained inaccessible to the 
protease at the end of the chase period. Mutant 476 +  did not 
become accessible to trypsin after synthesis at 37°C, a result 
consistent with its inefficient transport from the ER at that 
temperature. 
The data shown in Fig. 3 A also suggest that there may be 
variation in the stability of the mutant proteins at 37°C since 
there appears to be some loss of the labeled 54A+ and 188+ 
bands during the 2-h chase period, presumably due to degra- 
dation of these mutant proteins.  Extensive turnover of these 
two mutants and of mutant 54B+  was observed during ex- 
tended  chase  periods  of up  to  24  h  at  37°C  (results  not 
shown). In addition, the results shown in Fig. 3 indicate that 
the mature HA0, HA1, and HA2 forms of mutant  188+  mi- 
grate more slowly than the equivalent forms of other mutants 
which contain a supernumerary oligosaccharide.  HA 188+ 
thus appears to undergo more extensive terminal  gycosyla- 
tion  than  the  wild-type  protein,  due  in  part  to  increased 
modification of some or all of the oligosaccharide moieties 
and in part to conversion to the complex form of one of the 
two side chains that normally remain  in the mannose-rich 
form (Doyle et al.,  1986;  our unpublished  results). 
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of  the l~me Course of  Acquisition by WiM-type and 
Mutant XHA Proteins of  Resistance to Endo H 
% HA molecules resistant to endo H 
15 min p  +15 min chase  +2 h chase 
XHA  0  25  80 
XHA46 +  0  23  83 
XHA54A +  0  16  54 
XHA54B +  0  14  59 
XHA  188 +  0  12  77 
XHA255 +  0  30  76 
XHA476 +  0  3  7 
The  accuracy of the  densitometry measurements was  +3%  in  repeated 
analyses. 
Effect of Temperature on the Addition of 
Supernumerary Oligosaccharide Side Chains and on 
the lntracellular Transport of the Mutant Proteins 
It has been observed that the extent of glycosylation at in- 
dividual consensus sites can be affected by the temperature 
at which the protein is synthesized (Schuy et al.,  1986), pos- 
sibly due to alteration of the rate at which the nascent poly- 
peptide folds into a conformation that masks the consensus 
sequence.  We therefore analyzed the wild-type and mutant 
HA0 proteins after synthesis either at 30°C or at 42°C (Fig. 
3, B and C). Examination of the mobilities of the HA species 
by SDS-PAGE and autoradiography revealed that there was 
very little effect of temperature on the use of the natural or 
supernumerary glycosylation sites on the wild-type or mu- 
tant proteins (results not shown). The wild-type HA and mu- 
tants 46+,  54+, and 54B+  migrated as single components 
under all circumstances. Although there appeared to be some 
minor variability in the efficiency of use of the consensus se- 
quences in the other mutants (188+, 225+, and 476+) at the 
different temperatures, as evidenced by the appearance of an 
additional minor component having a mobility correspond- 
ing to the addition of one extra or one less oligosaccharide, 
this minor component did not comprise more than a few per- 
cent of the HA molecules. 
By contrast,  alterations  in the temperature  had dramatic 
effects on the transport of the mutant proteins  through the 
cell.  When the wild-type and mutant proteins were synthe- 
sized at 30°C, the majority of all the labeled proteins became 
accessible to trypsin within 4  h  of chase (Fig.  3  B).  Most 
notably, 75 % of the molecules of mutant 476+ moved to the 
plasma  membrane where they were cleaved into HA1  and 
HA2 subunits.  On the other hand,  after synthesis  at 42°C 
only wild-type XHA and two of  the mutants (46+ and 225+) 
became accessible to trypsin after 2  h  of chase (Fig.  3  C). 
The other mutants showed no evidence of processing to the 
Figure 3.  Effect  of temperature  on the  intraceUular  transport of 
wild-type and mutant XHA proteins.  CV-1 cells were infected for 
40 h at 37°C with SV40-HA recombinant viruses.  Monolayers of 
infected cells were pulse labeled  with [35S]methionine and then in- 
cubated in an excess of nonradioactive methionine,  as described in 
Materials  and Methods,  either at 37 (A), 30 (B), or 42°C (C). The 
intact monolayers were then treated  with DME (-) or DME con- 
taining 5 Itg/ml trypsin (+) for 15 min at the appropriate tempera- 
ture before cell extracts were prepared and analyzed by immunopre- 
cipitation  and SDS-PAGE as described in Materials  and Methods. 
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indicating that they were not transported from the ER at the 
higher temperature. 
None of the mutants displayed increased turnover after 
synthesis and transport to the cell surface at 30°C (Fig. 3 B). 
Nor did any of the proteins show evidence of degradation af- 
ter synthesis at 42°C  (Fig.  3  C).  It is likely that mutants 
54A+, 54B+, and 188+  remained intact at 42°C, despite 
being turned over more rapidly at 37°C, because they were 
retained in the ER and were not exposed to extracellular pro- 
teases. Retention in the ER also explains the lack of  proteoly- 
sis of mutant 476+ at 37°C, since this mutant is sensitive to 
degradation by trypsin after preparation of a cell extract (see 
below,  Fig.  6). 
Cellular Location of the Wild-type and 
Mutant Glycoproteins 
Indirect immunofluorescence using an antibody that recog- 
nizes all forms of HA was also used to analyze the cellular 
location of the wild-type and mutant proteins after synthesis 
at 37 or 30°C. At 37°C, permeabilized cells expressing either 
wild-type XHA or mutants 46+, 54B+,  188+, and 225+ 
displayed qualitatively similar patterns of labeling (Fig. 4). 
In addition to diffuse labeling of the cell surface, there is 
staining of the perinuclear Golgi region as well as reticular 
staining of the ER; a pattern that is typical of glycoproteins 
synthesized in the ER and transported to the cell surface via 
the Golgi apparatus.  The intensity of surface labeling ap- 
peared to be significantly decreased for the 54B+ and 188+ 
mutants (Fig. 4), a result consistent with increased extracel- 
lular degradation of these proteins at 37°C (see above,  Fig. 
3 A). Staining of nonpermeabilized cells confirmed that re- 
duced amounts of the 54B+  and 188+  mutants were dis- 
played on the plasma membrane (data not shown). Cells ex- 
pressing mutant 476+  showed no surface fluorescence but 
displayed a strong reticular staining pattern (Fig. 4). In addi- 
tion, there appeared to be a concentration of fluorescence in 
the juxtanuclear region which might be taken as evidence 
that 476+  molecules were also  located within the  Golgi 
cisternae.  In  this context,  the  results  shown in Table  III 
(above) indicated that ~7 % of mutant 476+ became resistant 
to endo H  during a  2-h chase period.  However,  we have 
reported previously (Doyle et al., 1986) that similar patterns 
of immunofluorescence were seen in control experiments in 
which infected CV-1 cells were stained with an antiserum that 
reacts specifically with antigens localized only in the ER. 
Furthermore, Poruchynsky et al. (1985) have shown by elec- 
tron microscopy that in COS-7 cells, which are derived from 
the CV-I cells used in our studies, the Golgi stacks in the jux- 
tanuclear region are spatially intertwined with an extensive 
ER, so that in this region bright but not totally coincident im- 
munofiuorescence can be obtained with probes for either ER 
or Golgi elements. Taken together, our data is consistent with 
the majority of the mutant 476+ protein synthesized at 37°C 
being retained in the ER and inefficiently transported along 
the secretory pathway.  Staining of nonpermeabilized cells 
confirmed that little or no mutant 476+  was transported to 
the cell surface at 37°C  (data not shown). 
After synthesis at 30°C, there was little difference between 
the patterns of  immunofluorescence  of  the wild-type and mu- 
tant proteins, all of which were displayed efficiently on the 
cell surface (data not shown). This result confirms the con- 
clusion drawn from the pulse-chase analysis (Fig. 3 B) that 
mutant 476+  can be efficiently transported to the plasma 
membrane at 30°C. 
Detection of  Structural Alterations 
Resulting from the Addition of  Supernumerary 
Oligosaccharide Side Chains 
The introduction of amino acid changes that ultimately direct 
the addition of posttranslational modifications may well alter 
the native structure of the protein. Structural alterations may 
arise as a consequence of the substitution of the individual 
amino acid residues, or the addition of the bulky N-linked 
glycan, or of a combination of these changes. Although we 
had attempted to minimize structural effects by careful selec- 
tion  of the  novel  sites  for  oligosaccharide addition,  we 
wished to assess if there had been any change in the local 
or global conformation of the mutant proteins. 
mAbs  prepared  against  wild-type XHA  were  used  as 
probes to detect any alterations in four major antigenic epi- 
topes on the mutant proteins. Three of the antigenic epitopes 
(sites A, B, and C) are located on the globular head of the 
molecule (see Fig. 7) and in general consist of exposed loops 
on the surface of the protein (Wiley et al., 1981). Antibodies 
specific for these sites have been observed to be relatively 
indifferent to changes in the global conformation of the HA 
molecule and to recognize both the monomeric and trimeric 
forms of the protein. However,  the fourth epitope (site D) 
maps in the trimer interface (Wiley et al., 1981) and appears 
to be displayed only when the molecule is in the fully folded 
trimeric form. Single amino acid changes (including those 
that result in addition or loss of an N-linked glycan) can alter 
or block recognition by mAbs specific for these sites (re- 
viewed by Wiley and Skehel, 1987). Because some of the an- 
tigenic epitopes may have been "masked" by the addition of 
novel side chains within or near the epitope, binding of the 
antibodies to the mutant proteins was analyzed after synthe- 
sis of the protein both in the absence and presence of tunica- 
mycin, a specific inhibitor of N-linked glycosylation  (Schwarz 
and Datema, 1980). Binding of the mAbs to the glycosylated 
and nonglycosylated  proteins was determined both by immu- 
noprecipitation of labeled HA (Fig. 5) and by indirect im- 
munofluorescence (Table III). 
Labeled proteins of the expected size (,~80 kD for the 
glycosylated molecules or 60 kD  for the nonglycosylated 
molecules) could be immunoprecipitated from extracts of 
cells expressing the wild-type and mutant HAs using mono- 
clonal antisera specific for the A, B, or C sites as well as by 
the polyclonal anti-X31  HA serum (Fig. 5). Unfortunately, 
the affinity of the site D antibody appeared to be insufficient 
for immunoprecipitation of HA under the  conditions we 
used, although it was suitable for use in immunofiuorescence 
experiments (see below). The majority of the mutants were 
recognized by all three A, B, and C mAbs. However, mutant 
54B+ was only weakly recognized by the C mAb, whether 
or not it was glycosylated. It is likely that this altered binding 
affinity may be due to the substitution of proline 55 by gly- 
cine. By contrast, the B mAb immunoprecipitated the non- 
glycosylated  form of mutant 188+ although it recognized the 
glycosylated protein only weakly at 37°C. This result indi- 
cates that residue 190 does not form part of the B antibody 
The Journal of Cell Biology, Volume  107, 1988  2066 Figure 4. Intracellular  localization  of wild-type and mutant XHA proteins expressed in CV-1 cells during growth at 37°C. 40 h after infection 
with SV40-HA recombinant  viruses, CV-1 cells were permeabilized and assayed by indirect immunofluorescence using a specific anti-X31 
HA polyclonal rabbit serum as described by Doyle et al. (1985). 
Gallagher et al. Effect of Supernumerary Oligosaccharides on Influenza HA  2067 Figure 5.  Recognition of wild-type and mutant XHA proteins by monoclonal antisera specific for the A, B, C, or D antigenic epitopes. 
CV-I cells infected for 40 h with SV40-HA recombinant viruses were labeled in the presence or absence of tunicamycin (5 ltg/ml) for 
1 h with  [35S]methionine. Cell extracts were prepared,  and proteins were immunoprecipitated  with one of four mouse mAbs directed 
against the A, B, C, or D antigenic sites on XHA. The precipitated proteins were analyzed by SDS-PAGE and autoradiographed. The mAbs 
used were the following: 11/4 (A)  17/2 (B), 69/1 (C), and 78/6 (D). X is a specific rabbit anti-XHA polyclonal antiserum. 
combining site since the substitution of Glu  190 by Ser to 
form the Asn=Gln-Ser consensus sequence did not prevent 
antibody binding in the absence of glycosylation. The weak 
recognition of the glycosylated protein could result either 
from  shielding  of the  region  by  the  oligosaccharide  side 
chain or from modification of the e-amino group of Asn188. 
Substitution  of this  residue  by aspartic acid has  been ob- 
served in virus variants that escape neutralization by the B 
antibody (Wiley and Skehel,  1987). 
Indirect immunofluorescence of permeabilized cells could 
be used to assay recognition of the wild-type and mutant HAs 
by the complete panel of mAbs since the D antibody recog- 
nized HA in immunofluorescence experiments. The results 
obtained are summarized in Table III. mAb A recognized the 
The Journal of Cell Biology, Volume  107, 1988  2068 Table IlL Effect of Temperature on the Antigenic Epitopes and Functional Activities 
of Wild-type and Mutant HA Glycoproteins 
Assay results at 37°C  Assay results at 30°C 
Binding to mAbs  Binding to mAbs 
RBC  Cell/cell  RBC  Cell/cell 
A  B  C  D  binding  fusion  A  B  C  D  binding  fusion 
XHA  +  +  +  +  >90%  +  +  +  +  +  +  +  >70%  +  +  + 
XHA46 +  +  +  +  +  >90%  +  +  +  +  +  +  +  >70%  +  +  + 
XHA54A  +  +  +  +  -  >90%  +  +  +  +  +  +  +  >70%  +  +  + 
XHA54B +  +  +  +  *  -  >90 %  +  +  +  +  +  +  +  >70 %  +  +  + 
XHA188+  +  +  +  -  0%  ++  +  +  +  +  +  5%  +++ 
XHA225 +  +  +  +  +  >90%  +  +  +  +  +  +  +  >70%  +  +  + 
XHA476 +  +  +  +  -  0 %  -  +  +  +  +  >70%  +  +  + 
The synthesis of HA glycoproteins at 37 or 30°C in CV-1 cells infected with SV40-HA recombinant viruses and the subsequent immunofluorescence, erythrocyte 
(RBC)  binding, and cell/cell fusion assays were carried out as described in Materials and Methods. 
*  _+  indicates weak recognition by the antibody. 
wild-type HA and all the mutant proteins, revealing fluores- 
cent-staining patterns similar to those seen with the poly- 
elonal antiserum (see Fig. 4). The patterns of recognition of 
the mutant proteins by the A, B, and C mAbs were consistent 
with those obtained using immunoprecipitation (Fig. 5). Af- 
ter synthesis at 37°C, only cells expressing the wild-type HA 
or mutants 46+  and 225+  displayed surface and internal 
fluorescence with mAb D. However, when the proteins were 
synthesized and accumulated at  30°C,  every mutant HA 
could be recognized by the D antibody, yielding an intense 
cell surface and internal staining pattern. Since the D anti- 
body appears to recognize an epitope that is formed solely 
when the globular domains at the top of the molecules are 
packed together correctly (Wiley et al., 1981), it seems that 
only mutants 46+  and 225+  display the  native trimeric 
structure at 37°C. However, all of the mutant proteins appear 
to be correctly folded and oligomerized at 30°C since all 
were recognized by the D antibody. 
Conformational changes in HA have been shown to en- 
hance its suceptibility to proteases, presumably by exposure 
of protease-sensitive sites which are inaccessible in the na- 
tive protein (Skehel et al., 1982; Doms and Helenius, 1986). 
We have shown previously that monomeric or improperly 
folded forms of HA are degraded by trypsin, while correctly 
folded HA trimers are resistant to degradation by the pro- 
tease although the HA molecules are cleaved into their com- 
ponent HA1 and HA2 chains (Gething et al.,  1986b).  The 
protease sensitivity of the wild-type and mutant proteins was 
determined by preparing cell extracts from infected, labeled 
cells in the absence of  protease inhibitors and then incubating 
the extracts with trypsin (25 lag/ml) for 15 min at 4°C. After 
the addition of an excess of soybean trypsin inhibitor, the HA 
polypeptides in the cell extracts were immunoprecipitated 
and separated by SDS-PAGE  (Fig. 6 A). Mutant 476+  was 
completely degraded by trypsin, suggesting that its structure 
is unfolded after synthesis at 37°C.  By contrast, wild-type 
HA and the other mutants were cleaved into HA1 and HA2 
subunits that were completely or largely resistant to further 
digestion by the protease at 4°C (Fig. 6 A). As observed in 
previous experiments (Figs. 3 A and 4), mutant 188+  dis- 
played increased susceptibility to degradation by trypsin, al- 
though significant amounts of intact HA1 and HA2 subunits 
remained after digestion of the cell extract at 4°C. 
After synthesis at 30°C, all the mutant proteins, including 
476+ (Fig. 6 B), were resistant to degradation by trypsin al- 
though they could be  cleaved into  stable  HA1  and HA2 
subunits. These results are consistent with all of the mutants 
becoming folded into the correct trimeric structure at the 
lower temperature. 
Functional Activities of Wild-type and Mutant HAs 
Functional HA displayed on the cell surface can be detected 
using  two  assays  which  reflect the  receptor-binding  and 
membrane-fusion activities of the  molecules that are  in- 
volved in the infectious entry of influenza virions into the 
host cell (for a review see Gething and Sambrook,  1983). 
The sialic acid-binding activity of HA can be monitored by 
hemagglutination of erythrocytes to infected cell monolayers 
(Gething and Sambrook, 1981). Table III summarizes the re- 
suits obtained when cells infected for 40 h with the various 
recombinant viruses were assayed for erythrocyte binding. 
At 37°C, >90% of the cells which expressed either the wild- 
type HA or the 46+, 54A+, 54B+, and 225+ HA mutants 
bound erythrocytes densely. However,  cells expressing two 
of the mutants (188+  and 476+) failed to bind erythrocytes 
after synthesis at 37°C. In the case of mutant 476+, this lack 
of binding is almost certainly the result of the failure to trans- 
port functional HA to the cell surface since expression at 
30°C  resulted in binding of erythrocytes to >70%  of the 
cells. Lackof transport of the mutant protein cannot provide 
the explanation for the  failure of cells expressing mutant 
188+  to bind significant numbers of erythrocytes, because 
adequate levels of functional protein are present at the cell 
surface after synthesis at either temperature (see Fig. 3 and 
results of the fusion assays discussed below). It is likely that 
the supernumerary oligosaccharide masks the activity of the 
sialic acid receptor either by shielding or disrupting the bind- 
ing site. 
We have shown previously that CV-1 cells expressing HA 
on their plasma membranes can be induced to fuse with each 
other after brief exposure to low pH  (White et al.,  1982; 
Gething et al., 1986a).  This results in the formation of large 
syncytial cells and occurs within a defined pH range. To ana- 
lyze the ability of the wild-type and mutant HAs to mediate 
low pH-induced fusion, infected CV-1 cells were first treated 
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 with trypsin to convert the precursor HA0 to the active form 
(Gething and Sambrook, 1982). The pH of the medium was 
then transiently decreased to values between 5 and 6 before 
incubation of the cells in normal medium for several hours 
to facilitate visualization of the formation of polykaryons. 
The results of these experiments and others performed after 
synthesis at 30°C are summarized in Table III. After synthe- 
sis at 37°C,  only mutant 476+  failed to mediate cell fusion 
within a pH range between 5 and 6. However, when synthe- 
sized at 30°C, all the mutant proteins could mediate the fu- 
sion reaction with the same pH dependence as that displayed 
by the wild-type protein. The failure to transport a sufficient 
amount of functional  HA to the cell  surface at 37°C  (see 
above and Fig. 3 A) provides the explanation for the lack of 
fusion of cells expressing mutant 476+.  More interestingly, 
the ability of mutant 188+  to mediate cell fusion despite its 
lack of hemagglutination activity demonstrates that binding 
of HA to sialic acid-containing residues on the target mem- 
brane is not a prerequisite for membrane fusion leading to 
polykaryon formation. 
Discussion 
We have constructed and expressed a  series of mutant HA 
molecules, each containing a new consensus site for glycosy- 
lation in addition to the seven sites normally found on the 
wild-type protein.  Knowledge of the precise three-dimen- 
sional structure of the X-31 HA molecule and of the amino 
acid sequences of a large number of other HAs from different 
virus strains allowed us to choose novel sites for glycosyla- 
tion which were located within five areas on the protein's sur- 
face that have not previously been shielded by an oligosac- 
charide side chain. We were successful in creating functional 
consensus sequences for glycosylation at four of the five sites 
that were mutated. The effects of the supernumerary oligo- 
saccharides on the structure, intracellular transport, and bio- 
logical activities of HA are summarized in Fig. 7. The results 
suggest that there are at least two reasons for the evolutionary 
exclusion of carbohydrate from specific areas of the surface 
of the  HA molecule;  attachment of an oligosaccharide at 
some positions can (a) interfere with the folding and assem- 
bly of the HA molecule and/or (b) shield or disrupt a func- 
tional region on the surface of the protein. However, attach- 
ment of an oligosaccharide side chain at one position (residue 
46) had no discernible effect on the structure or function of 
HA. It is possible that analysis of additional natural HA vari- 
ants might reveal one that contains carbohydrate attached at 
or near this site.  Alternatively, the presence of carbohydrate 
at  this  position  on the  molecule  may have been  selected 
against during evolution for a reason that we have not been 
able to assay in the tissue culture system used for this work, 
such as a defect in directional transport or virus assembly. 
This possibility is currently under investigation. 
We have previously shown that correct folding and trimeri- 
zation of HA is a prerequisite for efficient mobilization of the 
protein into the secretory pathway and that unfolded or par- 
tially folded forms of HA are unable to leave the ER (Gething 
et al.,  1986b). In this study we again observe that transport 
defects correlate with aberrant folding of the HA molecule. 
The only mutants that move to the Golgi apparatus with ki- 
netics similar to the wild-type protein are those (46+  and 
225+)  that achieve a  protease-resistant conformation and 
display the D antigenic epitope characteristic of the trimeric, 
wild-type  structure.  Those  mutants  (54A+,  54B+,  and 
188+) that display partial, temperature-sensitive defects in 
transport show parallel defects in folding as measured by for- 
225+  R~ 
GLY.LEU.SER  -~  ASN.LEU.SE 
-Site  not  glycosylated 
(steric  interference from Trp222?) 
-  -  Wild-type phenotype for transport 
and biological  activities 
-Antigenic epitopes (370C): 
A  +,  B  +,  C  +,  D  + 
-Antigenic epitopes (30°C): 
A  +,  B  +,  C  +"  D  +  A 
54B+ 
ASW.PRO.HIS  -4~  ASN.GLY.ITIR 
-Site  glycosylated 
-Transport slow at 37°C 
-Transport blocked at 420C 
-Antigenic epitopes (37°C): 
A  +,  B  +,  C-,  D- 
-Antigenic epitopes (30°C): 
A  +,  B  +,  C-,  D  + 
Intermediate  54A+ ASN.PRO.THR 
-Not glycosylated, has similar  ts 
phenotype 
-Antigenic epitopes (370C): 
A  +,  B  +, C  +,  D- 
-Antigenic epitopes (30°C): 
A  +,  B  +"  C  +,  D  + 
ALA.CYS.ILE  -$-  ASN.CYS.11~R 
-Site  glycosylated 
-Blocked in  ER  at  37°C 
(unfolded, protease sensitive) 
-Transports to plasma membrane in 
folded, biologically active form 
at 30°C 
-Antigenic epitopes (37~C): 
A  +,  B  +,  C  +, D- 
-Antigenic epitopes (30°C): 
A  +.  B  +.  C  +.  D  + 
B 
~D 
,C00(4 
188+ 
ASN.GLN.GLU  ~  ASN.GLN.SER 
-Site glycosylated 
-Sialic acid receptor site shielded 
(Erythrocyte binding negative; cell 
fusion  is  positive) 
-Transport slow at 37°C 
(conformation iS  more "open") 
-Transport blocked at 42°C 
-Antigenic epitopes (37°C)  : 
A  +,  B  +/-,  C  +,  D- 
-Antigenic  epttopes  (3OoC): 
A  +,  B  +,  C  +,  D  + 
46+ 
SER.SER.THR  -m~  ASN.SER.111m 
-Site  glycosylated 
-Wild-type  phenotype  for  transport 
and  biological  activities 
-Not temperature  sensltlve 
-Antigenic  epltopes  (3)°C): 
A  + ,  B  +"  C  + ,  O  + 
-Antigenic  epttopes  (30"C): 
A  + '  B  +"  C  +,  D  + 
Figure  7. Summary of the pheno- 
types  of mutants  having  super- 
numerary  consensus  sites  for 
glycosylation.  A drawing of the 
ectodomain of an HA monomer 
(Wilson et al.,  1981) shows the 
positions  of  the  seven  natural 
(open  stars  within  circles)  and 
five supernumerary glycosylation 
sequences (solid stars). The posi- 
tions of the four major antigenic 
epitopes (A, B, C, and D; Wiley 
et al.,  1981) are also shown. 
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transport of  mutant 476+ from the ER after synthesis at 37°C 
correlates with the protein remaining in an unfolded, pro- 
tease-sensitive conformation. Evidence from cross-linking 
studies suggests that 476+ does not assemble into trimers at 
37°C (our unpublished results). In the absence of structural 
information about this mutant, it would have been tempting 
to surmise that the oligosaccharide side chain attached to res- 
idue 476 inhibited the transport of the protein by shielding 
an epitope involved in exocytosis. However, the ability of the 
mutant to fold correctly and move normally along the secre- 
tory pathway after synthesis at 30°C disproves any role for 
shielding and confirms the importance of folding in facilitat- 
ing transport from the ER. 
In experiments aimed at determining whether oligosaccha- 
rides play a direct role in promoting protein transport to the 
cell surface, Machamer and Rose (1988a, b) have used oligo- 
nucleotide-directed mutagenesis to introduce novel glycosy- 
lation sites into the G protein of vesicular stomatitis virus. 
Because the three-dimensional structure of G is not known, 
these new sites were located in regions predicted by com- 
puter algorithms to be exposed in the folded molecule. Oligo- 
sacchaddes added at two new positions on the polypeptide 
chain could promote the cell surface expression of a G pro- 
tein lacking carbohydrate at the two normal sites, although 
the intracellular transport of these proteins was temperature- 
sensitive. Oligosaccharides added at four other positions on 
the polypeptide backbone did not promote the transport of 
the mutant G protein and in many cases interfered with the 
transport of G that is glycosylated at the two normal sites. 
It was concluded that the primary role of the natural oligo- 
saccharides in the intracellular transport of G protein lies in 
promoting proper polypeptide folding, as previously sug- 
gested by Gibson et al.  (1979). We have reached a similar 
conclusion for HA by using oligonucleotide-directed muta- 
genesis to remove the seven natural glycosylation sites in the 
X31-HA polypeptide chain, both singly and in combination 
(Gallagher, P., J. Hermeberry, J. Sambrook, and M.-J. Geth- 
ing,  manuscript  in  preparation).  Taken  together with  the 
results reported in this paper, these studies show that folding 
defects in glycoproteins can result either from the subtraction 
of natural oligosaccharide side chains or from the addition 
of supernumerary ones. Clearly, however, not all alterations 
in the folding or stability of these types of mutant glycopro- 
teins are attributable solely to the presence or absence of an 
oligosaccharide side chain (Santos-Aguardo et al.,  1987). 
The amino acid substitution(s) introduced to construct the 
novel consensus sites could by themselves affect the protein 
structure, despite care having been taken in this study to tar- 
get residues in HA that had not been conserved during evolu- 
tion. It is not possible for us to apportion the contribution 
of either the oligosaccharide side chain or the amino acid 
change(s)  in  HA to any folding defects because the non- 
glycosylated XHA molecules synthesized in the presence of 
tunicamycin are not assembled into native trimers or trans- 
ported from the ER (our unpublished results). However, it 
is apparent that the amino acid substitution of threonine for 
histidine in the 54A+ mutant is responsible for the observed 
folding and transport defects, since the proline residue in the 
center of the consensus sequence prevents addition of a su- 
pernumerary oligosaccharide chain. 
The long term goal of this study is to use supernumerary 
oligosaccharides to search for the location of functional epi- 
topes on the HA molecule. The ability of carbohydrate to 
shield surfaces of HA from the immune system has been 
demonstrated in  nature  during  the  antigenic  evolution of 
influenza viruses (reviewed by Wiley and Skehel, 1987). Se- 
lective pressure  during  evolution must  have  allowed  the 
emergence only of those  viruses containing mutated  HA 
molecules that can be efficiently incorporated into virions 
while maintaining function and thermostability. Thus evolu- 
tion limits the positions of novel glycosylation consensus se- 
quences to those where oligosaccharide addition has mini- 
mal effects on the folding, transport, and activity of the HA 
molecule. In our in vitro experiments with HA, it was not 
possible to use genetic selection to reveal the least disruptive 
locations for supernumerary glycosylation sites and choices 
had to be made based upon available knowledge of the se- 
quence and structure of the protein. However, we were able 
to select with high efficiency  sites at which attachment of  car- 
bohydrate, under the appropriate permissive conditions, did 
not prevent the transport of HA to the plasma membrane 
where it could be assayed for the display of functional epi- 
topes. Accurate pinpointing of new epitopes on HA depends 
upon the supernumerary oligosaccharides having only local 
effects on the structure of the molecule. The feasibility of the 
method is borne out by our observations (Table III and Fig. 
7) that after synthesis of the mutants at the permissive tem- 
perature of 30°C, none of the supernumerary oligosaccha- 
rides had any effect on the recognition of antigenic epitopes 
or the function of biologically active sites that lay at a dis- 
tance from the novel carbohydrate. 
This demonstration that in vitro mutagenesis can be used 
to produce transport-competent HA molecules containing 
supernumerary oligosaccharides that mask functional epi- 
topes raises the possibility that the method can be used as 
a general tool for shielding chosen areas of the surface of 
proteins that enter or traverse the secretory pathway. If assays 
are  available  to  rule out  effects of global  conformational 
changes, this method can be used either to pinpoint the loca- 
tion of functional epitopes on the surface of a protein or to 
mask the activity of a previously identified functional site. 
In both cases, the advantage of introducing a point mutation 
that leads to the addition of an oligosaccharide over one that 
causes only a single amino acid change lies in the increase 
in the area of  the protein whose function can be probed since 
an oligosaccharide side chain can shield an area covering a 
number of amino acids. In a search for a functional epitope, 
the  number of point mutants  that would need to be con- 
structed to probe the protein surface would be too large for 
the approach to be feasible in the absence of a genetic screen. 
However,  many  fewer  oligosaccharide-addition  mutants 
would suffice to survey the entire surface of a protein. 
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